133 related articles for article (PubMed ID: 29271149)
1. [Preparation and in vivo study of liposomes mediated by glycyrrhetinic acid derivative ligand 18-GA-Gly].
Jin S; Wang XL; Li G
Zhongguo Zhong Yao Za Zhi; 2017 Nov; 42(21):4120-4126. PubMed ID: 29271149
[TBL] [Abstract][Full Text] [Related]
2. Development of Salvianolic acid B-Tanshinone II A-Glycyrrhetinic acid compound liposomes: formulation optimization and its effects on proliferation of hepatic stellate cells.
Lin J; Wang X; Wu Q; Dai J; Guan H; Cao W; He L; Wang Y
Int J Pharm; 2014 Feb; 462(1-2):11-8. PubMed ID: 24374609
[TBL] [Abstract][Full Text] [Related]
3. [Liver targeting of compound liposomes mediated by glycyrrhetinic acid derivative receptor and its effect on hepatic stellate cells].
Wang XL; Guan HD; Qu SX; Xue BW; Li G; Liu XY; Chen LS; Gu H
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5195-5204. PubMed ID: 38114109
[TBL] [Abstract][Full Text] [Related]
4. [Preparation of salvianolic acid B, tanshinone Ⅱ_A, and glycyrrhetinic acid lipid emulsion and its protective effect against acute liver injury induced by acetaminophen].
Zhang XR; Lin T; Wang XL; Wang XJ; Gu H
Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(17):4634-4642. PubMed ID: 36164869
[TBL] [Abstract][Full Text] [Related]
5. Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy.
Qiu M; Wang J; Bai J; Li X; Tian C; Liu Z; Zheng C; Clark AR; Cheng X; Liao X; Wu S; Lee RJ; Zhou X
Mol Pharm; 2023 Apr; 20(4):1951-1963. PubMed ID: 36952242
[TBL] [Abstract][Full Text] [Related]
6. Glycyrrhetinic Acid Liposomes Containing Mannose-Diester Lauric Diacid-Cholesterol Conjugate Synthesized by Lipase-Catalytic Acylation for Liver-Specific Delivery.
Chen J; Chen Y; Cheng Y; Gao Y
Molecules; 2017 Sep; 22(10):. PubMed ID: 28946644
[TBL] [Abstract][Full Text] [Related]
7. The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid.
Li J; Xu H; Ke X; Tian J
J Drug Target; 2012 Jun; 20(5):467-73. PubMed ID: 22577855
[TBL] [Abstract][Full Text] [Related]
8. Modifying glycyrrhetinic acid liposomes with liver-targeting ligand of galactosylated derivative: preparation and evaluations.
Chen J; Chen Y; Cheng Y; Gao Y; Zheng P; Li C; Tong Y; Li Z; Luo W; Chen Z
Oncotarget; 2017 Nov; 8(60):102046-102066. PubMed ID: 29254224
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes.
Sun Y; Dai C; Yin M; Lu J; Hu H; Chen D
Int J Nanomedicine; 2018; 13():1621-1632. PubMed ID: 29588589
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of galactose-modified liposomes by a nonaqueous enzymatic reaction.
Guo BH; Cheng Y; Lin LP; Lin DH; Wu W
J Liposome Res; 2011 Sep; 21(3):255-60. PubMed ID: 21545336
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of tanshinone Ⅱ_A-glycyrrhetinic acid solid lipid nanoparticles and its inhibitory effect on acne].
Chen FN; Wang XL; Xu RR; Wang XJ; Ruan JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2449-2456. PubMed ID: 35531692
[TBL] [Abstract][Full Text] [Related]
12. A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation.
Chen J; Jiang H; Wu Y; Li Y; Gao Y
Drug Des Devel Ther; 2015; 9():2265-75. PubMed ID: 25945038
[TBL] [Abstract][Full Text] [Related]
13. Glycyrrhetinic acid proliposomes mediated by mannosylated ligand: Preparation, physicochemical characterization, environmental stability and bioactivity evaluation.
Chen J; Lin Y; Wu M; Li C; Cen K; Liu F; Liao Y; Zhou X; Xu J; Cheng Y
Colloids Surf B Biointerfaces; 2022 Oct; 218():112781. PubMed ID: 36007313
[TBL] [Abstract][Full Text] [Related]
14. Construction of redox-sensitive liposomes modified by glycyrrhetinic acid and evaluation of anti-hepatocellular carcinoma activity.
Hu J; Zheng Y; Wen Z; Fu H; Yang X; Ye X; Zhu S; Kang L; Li X; Yang X; Hu Y
Chem Phys Lipids; 2023 May; 252():105292. PubMed ID: 36931583
[TBL] [Abstract][Full Text] [Related]
15. HPLC assay and pharmacokinetics and tissue distribution study of glycyrrhetinic acid liposomes modified with galactosylated lipid.
Guo BH; Cheng Y; Wu W; Lin LP; Lin DH
J Liposome Res; 2012 Jun; 22(2):120-7. PubMed ID: 22313057
[TBL] [Abstract][Full Text] [Related]
16. A wogonin-loaded glycyrrhetinic acid-modified liposome for hepatic targeting with anti-tumor effects.
Tian J; Wang L; Wang L; Ke X
Drug Deliv; 2014 Nov; 21(7):553-9. PubMed ID: 24215357
[TBL] [Abstract][Full Text] [Related]
17. [Preparation of liposomes surface-modified with glycyrrhetinic acid targeting to hepatocytes].
Mao SJ; Hou SX; Jin H; Zhang LK; Jiang-Bin
Zhongguo Zhong Yao Za Zhi; 2003 Apr; 28(4):328-31. PubMed ID: 15139140
[TBL] [Abstract][Full Text] [Related]
18. Preparation and
Zhou T; Tang X; Zhang W; Feng J; Wu W
Drug Deliv; 2019 Dec; 26(1):673-679. PubMed ID: 31266376
[TBL] [Abstract][Full Text] [Related]
19. Insight into glycyrrhetinic acid: the role of the hydroxyl group on liver targeting.
Tian Q; Wang X; Wang W; Zhang C; Liu Y; Yuan Z
Int J Pharm; 2010 Nov; 400(1-2):153-7. PubMed ID: 20813176
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhetinic Acid Liposomes and Hyalurosomes on Spanish Broom, Flax, and Hemp Dressings to Heal Skin Wounds.
Abruzzo A; Cappadone C; Farruggia G; Luppi B; Bigucci F; Cerchiara T
Molecules; 2020 May; 25(11):. PubMed ID: 32486398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
